Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antibiotic Resistance of Helicobacter Pylori in Nanjing: A Cross-Sectional Study

NCT07455448 is registered in ClinicalTrials.gov with Nanjing First Hospital, Nanjing Medical University as lead sponsor.

NCT NCT07455448
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07455448 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antibiotic Resistance of Helicobacter Pylori in Nanjing: A Cross-Sectional Study
Lead sponsor
Nanjing First Hospital, Nanjing Medical University
Phase
Observational
Overall status
Completed
Start date
March 1, 2026
Completion date
March 25, 2026
Enrollment
7,227 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori infections